Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy resTORbio stock in Canada

Own resTORbio shares in just a few minutes.

Updated

Fact checked

resTORbio, Inc is a biotechnology business based in the US. resTORbio shares (TORC.US) are listed on the NASDAQ and all prices are listed in US Dollars. resTORbio employs 10 staff and has a market cap (total outstanding shares value) of $11.9 million.

How to buy shares in resTORbio

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: TORC in this case.
  5. Research resTORbio shares. The platform should provide the latest information available.
  6. Buy your resTORbio shares. It's that simple.

resTORbio share price

Use our graph to track the performance of TORC stocks over time.

resTORbio shares at a glance

Information last updated 2021-01-23.
Latest market close$N/A
52-week range$0.86 - $17.22
50-day moving average $7.3133
200-day moving average $2.6582
Wall St. target price$3
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.444

Compare online trading platforms

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost
Wealthsimple Trade
Stocks, ETFs
$0
N/A
$0
Free
Get a $25 bonus when you open a Wealthsimple Trade account and deposit and trade at least $100.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0 (if monthly commissions are greater than or equal to US$10.00)
Min. $1.00, Max. 0.5% of trade value
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Qtrade Investor
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, IPOs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, else $25/quarter
$0 - $8.75
Qtrade Investor offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95-$9.95
$9.95 + $1 per contract
$0
Free
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Scotia iTRADE
Options, Mutual Funds, ETFs, GICs, International Equities
$4.99-$9.99
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$0
$9.99 ($4.99 if completed 150 trades or more a quarter)
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
loading

Compare up to 4 providers

Name Product Minimum deposit to invest Funding methods Management fee Available asset types
Wealthsimple Invest
$1
Direct deposit, Bank transfer
0.40% - 0.50%
Stocks, Bonds, ETFs, Commodities
Get a $50 bonus when you open and fund your first Wealthsimple Invest account with a minimum initial deposit of at least $500. Trade and Cash accounts are not eligible.
CI Direct Investing (formerly WealthBar)
$1,000
Direct deposit, Bank transfer
0.35% - 0.60%
Mutual Funds, ETFs
CI Direct Investing offers access to an exclusive and personalized investment portfolio. Get up to $10,000 managed free for a year when you sign up for your first CI Direct Investing account and fund your account.
Justwealth
$5,000
Direct deposit, Bank transfer, Automatic bank withdrawals
0.50%
ETFs
Receive a cash bonus of $50.00-$225.00 when you open a new Justwealth account. RESP accounts require no minimum deposit to begin investing.
Moka
$0
Automatic bank withdrawals
$3/month
ETFs
The Moka app rounds up every purchase you make to the nearest dollar and invests the spare change into low-cost exchange-traded funds (ETFs).
loading

Compare up to 4 providers

Name Product Minimum Opening Deposit Commission Available Markets Platforms
Forex.com
US$100
Minimum US$25
Forex
Metals
Commodities
Indices
Shares
Forex.com Desktop, Forex.com Web Trading, Forex.com Mobile Trading, MetaTrader 4
CFDs are leveraged products which involves greater risk than using cash resources only. You could lose all or more of your initial investment. Trade 80+ currency pairs and 220+ CFDs in equities, commodities and indices on Forex.com.
loading

Compare up to 4 providers

Is it a good time to buy resTORbio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

resTORbio financials

Gross profit TTM USD$0
Return on assets TTM -38.47%
Return on equity TTM -66.75%
Profit margin 0%
Book value $1.941
Market capitalisation USD$11.9 million

TTM: trailing 12 months

How to short and sell resTORbio shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "TORC.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 560,879 resTORbio shares held short by investors – that's known as resTORbio's "short interest". This figure is 24.7% down from 744,667 last month.

There are a few different ways that this level of interest in shorting resTORbio shares can be evaluated.

resTORbio's "short interest ratio" (SIR)

resTORbio's "short interest ratio" (SIR) is the quantity of resTORbio shares currently shorted divided by the average quantity of resTORbio shares traded daily (recently around 683998.7804878). resTORbio's SIR currently stands at 0.82. In other words for every 100,000 resTORbio shares traded daily on the market, roughly 820 shares are currently held short.

However resTORbio's short interest can also be evaluated against the total number of resTORbio shares, or, against the total number of tradable resTORbio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case resTORbio's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 resTORbio shares in existence, roughly 10 shares are currently held short) or 0.0127% of the tradable shares (for every 100,000 tradable resTORbio shares, roughly 13 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against resTORbio.

Find out more about how you can short resTORbio stock.

resTORbio share dividends

We're not expecting resTORbio to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

resTORbio share price volatility

Over the last 12 months, resTORbio's shares have ranged in value from as little as $0.86 up to $17.22. A popular way to gauge a stock's volatility is its "beta".

TORC.US volatility(beta: 2.43)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while resTORbio's is 2.433. This would suggest that resTORbio's shares are significantly more volatile than the average for this exchange and represent a higher risk.

resTORbio overview

resTORbio, Inc., a clinical-stage biopharmaceutical company, develops medicine to treat aging-related diseases. Its lead program is selectively inhibits the target of rapamycin complex 1 (TORC1), an evolutionary conserved pathway that contributes to the age-related decline in function of various organ systems, including immune, neurologic, and cardiac functions. The company's lead drug candidate is RTB101, an oral, selective, and potent inhibitor of TORC1 that is in Phase 1b/2a clinical trial for the treatment of Parkinson's disease, as well as to treat neurodegenerative diseases. resTORbio, Inc. has collaboration with TrialSpark to investigate RTB-101 for COVID-19 on the Project Covalence platform. resTORbio, Inc. was founded in 2016 and is headquartered in Boston, Massachusetts.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site